Please login to the form below

Not currently logged in
Email:
Password:

product launches

This page shows the latest product launches news and features for those working in and with pharma, biotech and healthcare.

GSK gets maintenance indication for Trelegy

GSK gets maintenance indication for Trelegy

GlaxoSmithKline is celebrating an expanded US approval for its triple respiratory drug Trelegy, which it has long held up as one of its most important new product launches. ... The new product is still very much in its roll-out phase after getting FDA

Latest news

  • Gilead’s triple HIV drug approval prompts GSK lawsuit Gilead’s triple HIV drug approval prompts GSK lawsuit

    The US FDA approved Gilead Sciences’triple-drug Biktarvy product for HIV this week, but the company’s celebrations were swiftly undermined by a legal challenge from GlaxoSmithKline. ... which was first approved in the US in 2013 and is a key

  • AZ expects return to growth this year after 2017 decline AZ expects return to growth this year after 2017 decline

    in sales in China, although the cost of new product launches pegged back fourth-quarter profit.

  • 2018 by Darwin 2018 by Darwin

    Only a minority of such new product launches fulfil the promises made to their risk-exposed investors. ... We already see patients and their carers strongly influencing product choice in many pharma and medtech markets.

  • Merck forges closer ties with Cancer Research UK Merck forges closer ties with Cancer Research UK

    Its pipeline is currently spearheaded by PD-L1 inhibitor Bavencio (avelumab), partnered with Pfizer, and comes after a lean few years at the German company with few product launches and some

  • GSK’s R&D head Vallance departs, possibly for government role GSK’s R&D head Vallance departs, possibly for government role

    a major new wave of product launches until the early 2020s. ... She also said that it must make the most of near-term product launches - Shingrix shingles vaccine, dolutegravir-based HIV products and its triple therapy for chronic obstructive pulmonary

More from news
Approximately 0 fully matching, plus 141 partially matching documents found.

Latest Intelligence

  • Positive disruption in business intelligence Positive disruption in business intelligence

    During the years before a product launches, HCP ‘digital opinion leaders’ - online HCP influencers in a particular therapy area - may be identified who are advocating for a new product in development. ... Tactical opportunities. Listening to

  • Beyond the annual plan Beyond the annual plan

    In the last five years, the pharmaceutical industry has shifted from blockbusters in primary care to an increased number of high value specialty launches. ... This means more product launches in more indications, marketed to larger audiences than ever

  • ‘Dear Pharma, stop talking, start delivering’ ‘Dear Pharma, stop talking, start delivering’

    Hence, the resulting services and apps cater to one specific product or perhaps one disease. ... Reap the launch opportunity: Product launches allow leveraging global resources for developing an effective and globally scalable engagement programme.

  • The new launch paradigm The new launch paradigm

    To this end, it is imperative that new product launches are executed flawlessly and complement the overall corporate objective for consistent, successful multiple-product launches. ... More positively, the increasing recent and ongoing investment in

  • Social media and inflation penalties for generic drugs Social media and inflation penalties for generic drugs

    The timing and nature of concessions associated with product launches will have a significant influence on baseline product pricing, and could subsequently affect the profitability of the product throughout its life ... Manufacturers will also have to

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

  • Novo Nordisk target Ablynx reshuffles its board Novo Nordisk target Ablynx reshuffles its board

    Hensen is the ideal person to lead the board moving forward and his wealth of experience is particularly relevant as we advance towards the potential approvals and global launches of our ... lead, wholly-owned product, caplacizumab, in addition to

  • Astellas promotes John Demaree Astellas promotes John Demaree

    In his new role, Demaree will lead the promotion of in-market products, the preparation of product launches and will collaborate with Astellas' partner organisations in the region on marketing strategy.

  • The Medicines Company appoints Biogen's Tony Kingsley The Medicines Company appoints Biogen's Tony Kingsley

    Kingsley previously served as Biogen's executive vice president, global commercial operations, where the product launches he oversaw included the multiple sclerosis blockbuster Tecfidera (dimethyl fumerate).

  • Coloplast appoints new learning and development manager Coloplast appoints new learning and development manager

    Michelle has over 17 years of experience in training and development which involved systems training, training for new hires and product launches.

  • Nabriva Therapeutics adds Will Sargent to team Nabriva Therapeutics adds Will Sargent to team

    Sargent has over twenty years of experience in the biopharmaceutical industry, including multiple product and line extension launches. ... Nabriva is currently moving rapidly to advance its lead product, lefamulin, into phase III clinical studies which

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics